Details for Patent: 6,805,853

Title:	Delivery of diazepam through an inhalation route
Abstract:	The present invention relates to the delivery of diazepam through an inhalation route. Specifically, it relates to aerosols containing diazepam that are used in inhalation therapy. In a composition aspect of the present invention, the aerosol comprises particles comprising at least 5 percent by weight of diazepam. In a method aspect of the present invention, diazepam is delivered to a mammal through an inhalation route. The method comprises: a) heating a composition, wherein the composition comprises at least 5 percent by weight of diazepam, to form a vapor; and, b) allowing the vapor to cool, thereby forming a condensation aerosol comprising particles, which is inhaled by the mammal. In a kit aspect of the present invention, a kit for delivering diazepam through an inhalation route to a mammal is provided which comprises: a) a composition comprising at least 5 percent by weight of diazepam; and, b) a device that forms a diazepam containing aerosol from the composition, for inhalation by the mammal.
Inventor(s):	Rabinowitz; Joshua D. (Mountain View, CA), Zaffaroni; Alejandro C. (Atherton, CA)
Assignee:	Alexza Molecular Delivery Corporation (Palo Alto, CA)
Filing Date:	May 15, 2002
Application Number:	10/150,056
Claims:	1. A composition for delivery of diazepam comprising a condensation aerosol a) formed by volatilizing the diazepam under conditions effective to produce a heated vapor of the diazepam and condensing the heated vapor of the diazepam to form condensation aerosol particles, b) wherein said condensation aerosol particles are characterized by less than 5% diazepam degradation products, and c) wherein the aerosol MMAD is less than 3 microns. 2. The composition according to claim 1, wherein the condensation aerosol has a mass of at least 0.10 mg. 3. The composition according to claim 1, wherein the condensation aerosol particles comprise less than 2.5 percent by weight of diazepam degradation products. 4. The composition according to claim 1, wherein the condensation aerosol particles comprise at least 90 percent by weight of diazepam. 5. The composition according to claim 4, wherein the condensation aerosol has a mass median aerodynamic diameter less than 2 microns. 6. The composition according to claim 5, wherein the condensation aerosol particles comprise at least 97 percent by weight of diazepam. 7. A method of producing diazepam in an aerosol form comprising: a) volatilizing diazepam under conditions effective to produce a heated vapor of the drug, and b) during said volatilizing, passing air through the heated vapor to produce aerosol particles of the diazepam comprising less than 5% diazepam degradation products and an aerosol having an MMAD less than 3 .mu.m. 8. The method according to claim 7, wherein said volatilizing includes heating a thin layer which includes the diazepam and which is on a solid support having the surface texture of a metal foil, to a temperature sufficient to volatilize the diazepam from the thin layer. 9. The method according to claim 7, wherein the aerosol has a mass of at least 0.10 mg. 10. The method according to claim 7, wherein the aerosol particles are formed at a rate of greater than 0.85 mg/sec. 11. The method according to claim 7, wherein the aerosol particles comprise less than 2.5 percent by weight of diazepam degradation products. 12. The method according to claim 7, wherein the aerosol particles comprise at least 90 percent by weight of diazepam. 13. The method according to claim 12, wherein the aerosol has a mass median aerodynamic diameter less than 2 microns. 14. The method according to claim 13, wherein the aerosol particles comprise at least 97 percent by weight of diazepam. 15. The method according to claim 8, wherein the thin layer which includes diazepam on said solid support surface has a thickness between 1.3 and 5.1 microns.